A B S T R A C T We investigated the relationship of the kallikrein-kinin system and the renin-angiotensin system in the regulation of blood pressure, salt and water excretion, and renal blood flow. Normotensive and hypertensive black and white men were studied during unrestricted sodium intake as well as on a 10-meq/day sodium intake; potassium intake was held constant throughout the study (80 meq/day).
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During unrestricted sodium intake, urinary kallikrein activity was greater in white normotensives than white hypertensives or black normotensives. There was no difference (P > 0.05) between white and black hypertensives or between black normotensives and black hypertensives. All groups had greater urinary kallikrein activity on low sodium vs. unrestricted sodium intake, but the increase in black hypertensives was small, and they excreted significantly less kallikrein than the other groups on the low sodium diet. Plasma renin activity showed similar increments after sodium restriction in all groups. Urinary kallikrein activity correlated with renal blood flow in all groups except the black normotensives on low sodium intake. Renal blood flow could be correlated uniformly with log (urinary kallikrein activity/supine plasma renin activity) in all groups on either diet. Urinary sodium and potassium excretion and urine volume were not different among the groups. We concluide: (a) important racial differences exist in urinary kallikrein activity that are uinrelated to sodium or potassium excretion or urine volume; (b) dietary sodiuim restriction further delineates racial differences and suiggests alternative pathophysiologic mechanisms for human hypertension; (c) urinary kallikrein activity correlates with renal blood flow; and (d) our data INTRODUCTION Kallikrein is an enzyme that catalyzes the formation of the vasodilator hormones, lysyl-bradykinin (kallidin) and bradykinin, from a plasma alpha-2 globulin substrate, kininogen (1) . Urinary kallikrein appears to be derived from the kidney and differs from the enzyme that circulates in plasma (2) . It has been proposed that kallikrein exists in the renal cortex and may occupy a location that is juxtaposed to the enzyme renin (3) . Although a physiologic function for lysyl-bradykinin, the enzymatic product, has not been established, pharmacologic infusion studies have shown that the peptide is a natriuretic and vasodilatory compound (4) .
A number of studies in humans and experimental animals have attempted to determine the relationship between urinary kallikrein activity and blood pressure regulation (5) (6) (7) (8) (9) . Although most investigators feel that kallikreins could influence blood pressure, the meaning of these findings is controversial. Based on provocative preliminary observations (10) and the aforementioned studies, it seemed appropriate to examine the simultaneous influence of race and blood pressture on urinary kallikrein activity. In addition, we have examined the association between kallikrein in uirine and factors that have been related to blood pressure regulation including urinary volume, soditum excretion, plasma renin activity, and renal blood flow. These latter studies were designed to determine a possible physiologic role for the kallikrein-kinin system in blood pressure control.
The Journal of Clinical Investigation Volume 60 July 1977 *129-138 METHODS Patients. Four groups of men (38 white and 21 black) with differing blood pressure patterns were studied at the Diagnostic and Treatment Unit of the San Diego Veterans Administration Hospital. The subjects included 25 hypertensive patients (18 white, 7 black) and 34 apparently healthy men (20 white, 14 black). All subjects were screened several times before hospitalization, and all hypertensive patients were required to exhibit the arbitrary criteria consisting of a supine mean arterial pressure (diastolic blood pressure plus one-third pulse pressure) that was at least 110 mm Hg on each determination. Apparently healthy normotensive men were paid volunteers who fulfilled the arbitrary criteria of a supine mean arterial pressure that was consistently less than 95 mm Hg during at least three separate measurements. Every subject gave his informed written consent, and the Committee on Human Experimentation of the University of California, San Diego, approved the protocol.
Each subject was admitted to the hospital and the evaluation consisted of a complete history and physical examination; multiple determinations of blood pressure (vide infra); routine blood chemical studies including determinations of the blood urea nitrogen concentration and the serum concentrations of sodium, potassium, chloride, bicarbonate, magnesium, calcium, and creatinine; a hemogram, a complete urinalysis including microscope examination of the urinary sediment and urine culture, a roentgenogram of the chest, and an electrocardiogram. While ingesting a diet with defined quantities of sodium and potassium (vide infra), each subject provided urine for two consecutive 12-h measurements of kallikrein activity, creatinine, sodium and potassium concentrations. In addition, samples of peripheral venous blood were obtained for the determination of plasma renin activity (PRA).'
Patients who met our arbitrary criteria for hypertension were evaluated further for known secondary causes of blood pressure elevation. These studies included an intravenous urogram, selective renal angiography with measurements of PRA in the renal venous effluent from the two kidneys, and the 24-h urinary excretion of 17-hydroxycorticosteroids, catecholamines, and vanillylmandelic acid. Only two patients had received previous therapy for hypertension, and in both instances medication was omitted for 3 wk before enrollment in the study.
Procedures
Each hypertensive patient was studied during two separate balance periods of dietary salt ingestion. During the initial phase (5 days) of hospitalization, subjects were fed a diet without restriction of sodium content (>100 meq/24 h) and which contained approximately 80 meq/24 h of potassium. Repeat urinary investigations were performed on the 11th hospital day after 5 days of restricted sodium ingestion (<10 meq/24 h) with supplementary oral potassium to a total intake of 80 meq/24 h, and further plasma samples for renin determination were obtained during the final hospital day (day 12) . Normotensive volunteers were studied on a similar protocol but were, of necessity, different subjects during each extreme of dietary salt ingestion.
On the day before the end of each phase of dietary sodium balance a 24-h urine collection was obtained to document 'Abbreviations used in this paper: A,, angiotensin I; EU, esterase units; PRA, plasma renin activity; TAME, p-tosyl arginine methylester. the achievement of a stable sodium balance. On the following day, two consecutive 12-h urine collections were obtained for the measurement of kallikrein activity, volume, and sodium and potassium concentration. Urine was stored in a refrigerator at 4°C immediately after each voiding. After the completion of a 12-h collection, the volume was measured in a graduated cylinder and an aliquot was frozen at -300C for later analysis.
On the day after the final urine collection of each phase of the balance study, renal blood flow was estimated by the method of constant infusion of p-aminohippurate without urine collection (11) Kallikrein activity was measured for p-tosyl arginine methylester (TAME) hydrolysis by using the radiochemical method of Beaven et (17) . EU is defined as that amount of enzyme which catalyzes the hydrolysis of 1 .imol TAME/min under the conditions of the assay, pH 8.5 and 37°C. This EU is equivalent to 12.5 Frey units (15) . Similar to previous investigations (18), we have found that the hydrolysis of TAME by urinary kallikrein at pH 8.5 and 370C proceeds by a factor of 1.6 filster than the TAME hydrolytic activity at pH 8.0 and 30°C, standard conditions To validate the relationship of TAME esterolytic activity measurements to human urinary kallikrein activity, we performed a bioassay with an anesthetized rat as previously described (18) . The catheterized femoral artery of an anesthetized Munich-Wistar rat was connected to a Statham blood pressure transducer (Statham Instruments Div., Gaiild Inc., Oxnard, Calif.) and solutions were injected via a catheter in the jugular vein. The preparation was standardized via incremental injections of bradykinin, and the hypotensive response was noted to be linear. A proportional decrease in blood pressure was observed with increasing amounts (n = 15) of partially purified human urinary kallikrein preparation (r = 0.99). Samples (n = 20) of desalted urine from normotensive and hypertensive black and white men assayed by the TAME esterolytic method produced a similar response over the range of esterase activities observed in this study (r = 0.88). TAME esterase activity of the same raw urines assayed with an internal standard exhibited a correlation (r = 0.95) that approximated the purified enzyme preparation. Pancreatic trypsin inhibitor blocked the hypotensive response and other proteolytic enzymes such as trypsin had no effect. Statistics Student's t test and linear regression analysis were performed using standard techniques (19 
RESULTS
All groups of men exhibited similar characteristics (Table I) . White hypertensives ranged in age from 2 to 57 yr (mean 37.8+2.8 yr) and did not differ (P > 0.10) from black hypertensives who averaged 41.4±4.7 yr (range 28-57 yr). In addition, hypertensive patients did not differ in age from any group of normotensive subjects (P > 0.10). Analysis of automated blood pressure patterns revealed the expected differences between those subjects previously and arbitrarily classified as hypertensive and those defined as normotensive (Table I ). The average automated mean arterial pressure of white hypertensive men was 114.5 ±1.4 mm Hg (range 108-126 mm Hg) and was similar (P >0.10) to black hypertensive men (mean 121.6 ±3.6 mm Hg, range 113-141 mm Hg). Regardless of race or dietary salt intake, all normotensive subjects exhibited blood pressures that were similar to each other (P > 0.10) but differed (P < 0.01) from all hypertensive men. Serum sodium and potassium concentrations were similar (P > 0.10) in all groups of subjects, and all exhibited normal renal function by the criteria of serum creatinine concentrations (Table I) and urinary examination. Results of all other diagnostic procedures were within the normal range for all hypertensive patients, and thus they were considered to have primary (essential) hypertension. Dietary salt intake or race did not influence these results in any group (Table I) . Urinary sodium excretion is summarized in Table II . There were no differences between sodium excretion on the day before urinary kallikrein measurement and the 24- which kallikrein was measured in any of the four groups. Additionally, every subject had decreased his urinary sodium excretion to less than 40 meq/24 h by the 4th day of the low sodium phase and in no instance was this value more than 5 meq greater than the 5th day, documenting that stable sodium balance was attained.
Urinary kallikrein activity differed among groups according to race and blood pressure pattern, and these differences showed distinct changes after dietary salt restriction (Tables III and IV) (Fig. 1) . After dietary salt restriction (Table IV, Fig. 1 (Tables III-V) . However, stimulated PRA on unrestricted sodium diet for black hypertensive men (mean, 1.0+0.4 ng AVml per h) was significantly less (P < 0.025) than that of apparently healthy black men who averaged 4.3 ±1.0 ng A/ml per h. There were no other differences (P > 0.10) among the compared groups during unlimited salt intake. A comparison of groups on restricted sodium intake indicated that there were no significant differences (P > 0.05) among subjects irrespective of race or blood pressure pattern (Table V) . We also contrasted supine vs. stimulated PRA at both extremes of salt intake (Tables III-V) . It is noteworthy that black hypertensive men alone did not exhibit an increase of PRA (P > 0.05) after our standard stimulation during either dietary manipulation. All other groups on either diet increased PRA consistently after the stimuli of furosemide and ambulation. However, dietary salt restriction resulted in a significant increment (P < 0.05) of PRA in all groups regardless of position (Table V) .
Renal blood flow was determined from the formuila: renal blood flow = p-aminohippurate clearance/(1-hematocrit). Data for renal blood flow are expressed as square meters of body surface area (Tables III and  IV) . On unrestricted sodium intake white normotensives had a renal blood flow of 570+13 ml/min per m2, UnNa+, unrestricted sodium diet; LNa+, low sodium diet.
+23 ml/min per m2) was significantly (P < 0.05) greater than for black hypertensives (360±35 ml/min per m2). Black hypertensives had significantly (P < 0.01) lower renal blood flow than black normotensives, whereas the difference between white normotensives and hypertensives did not reach significance (P > 0.05).
To investigate a possible relationship among urinary kallikrein activity, PRA (supine and stimulated), mean arterial pressure, urinary sodium and urinary potassium excretion, renal blood flow, and urine volume, we performed a linear regression analysis using these measurements. These associations were evaluated for each of the four groups (white hypertensives, white normotensives, black hypertensives, and black normotensives). In addition, we analyzed each racial group regardless of blood pressure pattern (Table V) . All blacks on restricted salt exhibited a significant negative correlation (r = -0.52, P < 0.05) between urinary kallikrein activity and supine PRA. While ingesting an unlimited sodium diet, black normotensives exhibited a significant correlation (r = 0.67, P < 0.05) between urinary kallikrein activity and stimulated PRA, and black hypertensive men had a significant inverse correlation (r = -0.85, P < 0.01) between urinary kallikrein activity and a 24-h sodium excretion. For all 12 comparisons that were made we found significant correlations between urinary kallikrein activity and renal blood flow in all groups except black normotensives on the low sodium diet (Table VI) . To blood pressure, whereas it was significantly (P < 0.05) lower in white hypertensive (mean: 9.2+2.3 EU) and black hypertensive (mean 3.0+ 1.1 EU) patients (Fig.  1) . Urinary kallikrein activity was also low in black normotensive men (average: 3.8+0.9 EU). After dietary salt restriction, urinary kallikrein activity increased (P < 0.05) in all subjects irrespective of blood pressure (Fig. 1) . All white subjects and black normotensives exhibited urinary enzyme activities that were similar (P > 0.05) to each other. However, kallikrein activity was significantly less (P < 0.05) in hypertensive black men than in any other group. Thus, urinary kallikrein activity appears to reflect a fundamental difference between black and white men with essential (primary) hypertension.
The demonstrations of biologic differences between racial groups is not without precedent. Several examples include the higher prevalence of decreased intestinal lactase activity in blacks (20) , the increased percentage of blacks with erythrocyte glucose-6-phosphate dehydrogenase deficiency (21) , and the variable prevalence rates of many types of neoplasia between races (22) . More relevant to our own results, there are experimental and epidemiologic reports that suggest fundamental differences between blacks and whites with primary hypertension. The latter studies have noted racial variability regarding possible pathophysiology, sequela of untreated disease, and response to antihypertensive therapy. We have observed previously, in a limited number of patients, that black hypertensive men exhibit greater plasma volumes than white hypertensives after correction for body surface areas (10) . In addition, one type of "low renin" hypertension appears to be more common among blacks (23) , and another study suggests that hypertensive whites exhibit a greater decrement of blood pressure after the administration of propranalol (24) .
Previous investigations ofthe kallikrein-kinin system in man have not been analyzed for a racial influence. Margolius et al. (25) reported that 21 patients with essential hypertension (unspecified race and dietary salt intake) excreted only half the quantity of urinary kallikrein as apparently normal controls. Subsequently, the same group (7) observed diminished urinary kallikrein activity in 11 patients with essential hypertension (eight blacks and three whites). Hypertensives exhibited a blunted but significant rise in urinary kallikrein excretion after dietary sodium restriction. Although our kallikrein assay procedures (including bioassay correlations) are similar, our differing criteria for hypertension and separate racial analysis do not allow a detailed comparison with these studies.
To the extent that multiple factors may be associated with the etiology of primary or essential hypertension, we have examined renal blood flow and PRA in our subjects. This further investigation would be supported by the proposal that kallikrein originates in the renal cortex near the distal tubule similar to renin (26) . In addition, kallikrein and renin appear to occupy the same anatomic location in the submaxillary glands of the mouse (27, 28) . Finally, animal and human experiments are consistent with an interrelated antagonism and modulation (29, 30) . The significant correlations that were found between urinary kallikrein activity and renal blood flow in all groups (Table VI) , except black normotensives on low sodium intake, are compatible with the concept that the kallikrein-kinin system may contribute to the regulation of renal vascular resistance. We have no explanation for our failure to document this relationship in the black normotensives except that it may represent a chance occurrence based on the size of this subject group. This conclusion does not preclude the possibility that other factors are more important in the regulation of renal blood flow in normotensive black men on restricted salt diets. The black hypertensive group had a significantly lower renal blood flow on the low sodium diet when compared to white hypertensives even though a difference did not exist on the unrestricted sodium intake. An attempt was made to explain further the observed racial variation in renal blood flow by relating this measurement to the proposed antagonism between the vasodilatory kallikreinkinin system and the vasoconstricting renin-angiotensin system. This was done by correlating renal blood flow (per square meters of body surface area) with log (urinary kallikrein/PRA supine) for normotensives and hypertensives on both diets (Figs. 2 and 3) . Significant correlations were found in all cases, and these observations provide support for the concept that both the kallikrein-kinin system and renin-angiotensin system are important regulators of renal blood flow in man. Thus, the lower urinary kallikrein activity in black hypertensives (compared to white hypertensives with similar blood pressures) on the low sodium diet is paralleled by a lower average renal blood flow. This is seen graphically in Fig. 3 by the tendency for the black hypertensives to cluster closer to the origin of the regression line. To the extent that diminished renal blood flow reflects increased renal vascular resistance in black hypertensives on low salt, we have demonstrated another pathophysiologic explanation for hypertension in the black population. A more prospective investigation will be required to define the exact relationship between our enzyme measurements and renal hemodynamics. However, it should be noted that our interpretation of these results is consistent with reports that renal vascular resistance contributes importantly to the genesis of hypertension, and we have provided evidence for a biochemical basis for this phenomenon (31 A proposal that the renal killikrein-kinin system (as reflected by urinary enzyme activity) is natriuretic in human subjects remains controversial. It has been suggested (34) and denied (15) that a positive relationship exists between urinary sodium excretion and kallikrein activity. In an attempt to reconcile apparent differences, Nasjletti and Colina-Chourio have proposed a reduced natriuretic potential for the kallikrein-kinin system after plasma volume contraction (35) . However, the present and previous observations (15) of incremental urinary kallikrein excretion in normal subjects after documented steady-state volume contraction seem incompatible with the concept that kallikrein is an important chronic natriuretic substance in normotensive humans. Yet, our present study does not enable us to draw conclusions regarding the importance of the kallikrein-kinin system in the more acute or even day-to-day regulation of salt excretion and control of extracellular fluid volume. It is attractive to propose that the previously reported volume expansion of black hypertensive men (10) may be related to deficient renal kallikrein and that this could be of pathophysiologic importance in this racial group. The observed negative correlation (r = -0.85, P < 0.01) between urinary sodium concentration and kallikrein activity in black men on unrestricted salt intake would be consistent with a deficiency of kallikrein, a potentially natriuretic substance. In black hypertensives, this latter defect might be synergistic with the previously proposed deficiency of a renal or systemic vasodilatory hormone.
Diurnal rhythms exist for a number of biologic systems including cortisol and aldosterone (36) . Based on the proposed mineralcorticoid influence on urinary kallikrein excretion (15) we have attempted to measure a possible broad day-night variation of the urinary enzyme. We observed day-night variation among white hypertensive patients but were unable to demonstrate a similar phenomenon in other studied groups (Tables III and IV) . Interestingly, white hypertensives had similar variability of urinary volume and sodium. This observation might be related to the larger number of hypertensive white subjects or may have physiologic meaning regarding blood pressure and volume regulation. Larger numbers of subjects and more frequent urine collections will be required to elucidate this observation further.
In conclusion, we have demonstrated racial and dietary influences on urinary kallikrein excretion in normotensive and hypertensive subjects. Additionally, racial variations in renal blood flow have been documented. We have observed a direct relationship between renal blood flow and urinary kallikrein excretion in all subjects except black normotensive men on a low sodium diet, and have shown a broad daynight variation of urinary kallikrein activity in white hypertensive patients. Finally, we have proposed several possible pathophysiologic mechanisms, based on these measurements, to explain differences in human hypertension which exist between the black and white races. Although further study is necessary, it appears that measurements of urinary kallikrein activity may provide a means to further our understanding of the physiologic basis for human hypertension.
